A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination
Clinical trial NCT02606877 · COMPLETED
Trial details
- NCT number
- NCT02606877
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-19
- Primary completion
- 2017-03-22
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.